Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Elshaikh

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 24, 2022
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomasTracy Sherertz, Anuja Jhingran, Matthew Biagioli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Comparison of biochemical failure definitions for permanent prostate brachytherapyDeborah A Kuban, Larry B Levy, Louis Potters, et al.
Journal of Applied Clinical Medical Physics|August 11, 2021
How does CBCT reconstruction algorithm impact on deformably mapped targets and accumulated dose distributions?Weihua Mao, Chang Liu, Stephen J Gardner, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2014
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSvend O Freytag, Hans Stricker, Mei Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional TrialDaniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 24, 2022
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomasTracy Sherertz, Anuja Jhingran, Matthew Biagioli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Comparison of biochemical failure definitions for permanent prostate brachytherapyDeborah A Kuban, Larry B Levy, Louis Potters, et al.
Journal of Applied Clinical Medical Physics|August 11, 2021
How does CBCT reconstruction algorithm impact on deformably mapped targets and accumulated dose distributions?Weihua Mao, Chang Liu, Stephen J Gardner, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2014
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSvend O Freytag, Hans Stricker, Mei Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional TrialDaniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Pageof 4